FDA Approves Paxil for Hot Flashes


Against the recommendation of its advisory committee on reproductive drugs, the Food & Drug Administration approved the use of a low-dose version of Paxil for hot flashes in menopausal women. The advisory committee had found that low-dose Paxil was not clinically  more effective in reducing hot flashes than was a placebo, and voted against approval.

Article →


Previous articleRethinking Mental Health, Part 1: From Positivism to a Holistic/Organismic Paradigm
Next articleParental Communication Deviance as a Risk Factor for Psychosis
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].